GO:0001016 RNA polymerase III transcription regulatory region sequence-specific DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001016 describes the molecular function of binding to DNA regions that control RNA polymerase III (Pol III) transcription, either sequence-specifically or after recruitment by other factors.
• This activity is essential for Pol III to recognize and initiate transcription at tRNA, 5S rRNA, and other small RNA genes.
• Sequence-specific DNA binding by Pol III general transcription factors, such as TFIIIC, nucleates the assembly of the Pol III preinitiation complex.
• Termination of Pol III transcription also relies on sequence-specific signals, including a non-template strand element, highlighting the broad role of DNA sequence recognition.
• Dysregulation of Pol III transcription and its regulatory DNA binding is linked to cancer, neurodegeneration, and other diseases.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of these DNA-binding events and their downstream effects.
Description
RNA polymerase III (Pol III) transcribes essential small RNAs, including tRNAs, 5S rRNA, and U6 snRNA, which are required for protein synthesis and RNA processing. The precise recruitment of Pol III to its target genes depends on the recognition of specific DNA sequences within regulatory regions. GO:0001016, RNA polymerase III transcription regulatory region sequence-specific DNA binding, captures the molecular function of proteins that bind these DNA elements, either directly through sequence-specific interactions or indirectly after being recruited by other factors. This function is fundamental for the assembly of the Pol III preinitiation complex and for the accurate initiation of transcription. Understanding GO:0001016 is critical because it defines the first step in Pol III gene activation: the physical engagement of transcription factors with DNA. For example, the general transcription factor TFIIIC binds to B-box and A-box elements in tRNA genes, serving as a platform for the recruitment of TFIIIB and Pol III. Sequence-specific DNA binding is also exploited by regulatory proteins that repress Pol III transcription, such as p53, which can inhibit snRNA gene transcription independently of direct sequence-specific DNA binding. Moreover, termination signals for Pol III include a non-template strand sequence-specific element, underscoring the pervasive role of DNA sequence recognition in Pol III biology. Researchers studying Pol III regulation need to identify the DNA-binding proteins and the cis-elements they recognize. This article integrates the QuickGO definition with verified literature to outline the mechanisms, key genes, disease relevance, and experimental strategies for investigating GO:0001016. By focusing on sequence-specific DNA binding, we provide a framework for understanding how Pol III transcription is controlled and how its dysfunction contributes to human disease.
RNA polymerase III transcription regulatory region sequence-specific DNA binding At A Glance
| GO ID | GO:0001016 |
|---|---|
| GO term | RNA polymerase III transcription regulatory region sequence-specific DNA binding |
| Ontology | molecular_function |
| Synonym | RNA polymerase III regulatory region DNA binding |
| Major function | Binding to DNA regions that control RNA polymerase III transcription, either sequence-specifically or after recruitment by other factors |
| Definition source | QuickGO |
| Related process | RNA polymerase III transcription initiation and regulation |
| Example proteins | TFIIIC subunits, TFIIIB subunits, Pol III subunits with DNA-binding domains |
What Is GO:0001016?
GO:0001016 is a molecular function term defined as binding to a DNA region that controls the transcription of a gene by RNA polymerase III. The binding may be sequence-specific or may occur only after a factor has been recruited to the DNA by other factors. In essence, it describes the ability of proteins to recognize and attach to regulatory DNA elements that govern Pol III transcription, thereby influencing the initiation or regulation of Pol III-dependent genes.
Why Is RNA polymerase III transcription regulatory region sequence-specific DNA binding Important in Cell Biology?
GO:0001016 is important because it represents the molecular recognition step that initiates Pol III transcription, a process essential for the production of tRNAs, 5S rRNA, and other small RNAs required for cell growth and proliferation. Dysregulation of Pol III transcription is observed in cancer and other diseases, and the DNA-binding activities of Pol III factors are often targeted by oncogenes and tumor suppressors. Thus, understanding this function provides insights into basic gene regulation and offers potential therapeutic targets.
• Essential for the synthesis of tRNAs and 5S rRNA, which are required for protein translation.
• Involved in the regulation of Pol III gene expression in response to growth signals and stress.
• Sequence-specific DNA binding by TFIIIC determines the selection of Pol III target genes.
• Termination of Pol III transcription depends on a non-template strand sequence-specific signal, linking DNA binding to transcription termination.
• Dysregulation of Pol III transcription contributes to cancer, neurodegeneration, and developmental disorders.
• p53 represses Pol III transcription of snRNA genes independently of sequence-specific DNA binding, highlighting alternative regulatory mechanisms.
• Zorro LNA can sequence-specifically inhibit Pol III-dependent transcription, demonstrating the druggability of these DNA elements.
• TATA box orientation can determine RNA polymerase II/III specificity, showing the interplay between promoter architecture and Pol III recruitment.
• Cell type-specific chromatin looping involving Pol III general transcription factors suggests a role in higher-order genome organization.
• CRISPR screens can identify genes that regulate Pol III DNA binding and transcription, offering new therapeutic targets.
Mechanism, Genes and Research Methods
What Happens During RNA polymerase III transcription regulatory region sequence-specific DNA binding?
In simple terms: This section explains the step-by-step process of how proteins bind to DNA regions that control RNA polymerase III transcription.
The process begins with the recognition of specific DNA sequences within Pol III-transcribed genes, such as the A-box and B-box elements in tRNA genes. The general transcription factor TFIIIC binds to these elements in a sequence-specific manner, serving as a scaffold for the recruitment of TFIIIB and Pol III. In some cases, binding may occur only after other factors have recruited the DNA-binding protein to the regulatory region, as seen with certain repressors. Once bound, these factors nucleate the assembly of the preinitiation complex, leading to transcription initiation. Termination also involves sequence-specific DNA binding, with a non-template strand element recognized by Pol III. Thus, DNA binding is a dynamic and multi-step process that ensures precise control of Pol III transcription.
Structure and Composition of RNA polymerase III transcription regulatory region sequence-specific DNA binding
In simple terms: This section describes the proteins and DNA elements that make up the DNA-binding machinery for Pol III transcription.
The core components include the multi-subunit general transcription factors TFIIIC and TFIIIB, as well as Pol III itself. TFIIIC is composed of six subunits (TFIIIC1, TFIIIC2, TFIIIC5, TFIIIC6, TFIIIC63, and TFIIIC90 in humans) and contains DNA-binding domains that recognize A-box and B-box elements. TFIIIB consists of TBP, BRF1, and BDP1, which are recruited to DNA via protein-protein interactions with TFIIIC. The DNA regulatory regions typically contain conserved sequence motifs, such as the TATA box, which can influence Pol III specificity depending on its orientation. Additionally, chromatin looping brings distant regulatory regions into proximity with Pol III genes, involving cell type-specific factors. The structural integrity of these protein-DNA complexes is essential for accurate transcription.
Molecular Mechanism of RNA polymerase III transcription regulatory region sequence-specific DNA binding
In simple terms: This section explains how proteins physically interact with DNA sequences to control Pol III transcription.
At the molecular level, sequence-specific DNA binding is mediated by conserved DNA-binding domains within transcription factors. For example, TFIIIC subunits contain helix-turn-helix or zinc-finger motifs that insert into the major groove of DNA, making base-specific contacts with A-box and B-box sequences. This binding is highly cooperative and can be modulated by post-translational modifications. In the case of termination, a non-template strand sequence-specific signal element is recognized by Pol III, leading to transcription termination. Some factors, such as p53, can repress Pol III transcription without direct sequence-specific DNA binding, instead interacting with other DNA-bound factors. The binding affinity and specificity are influenced by local chromatin structure and the presence of cofactors. Overall, the molecular mechanism ensures precise and regulated recruitment of Pol III to its target genes.
Regulation of RNA polymerase III transcription regulatory region sequence-specific DNA binding
In simple terms: This section describes how the DNA-binding activity of Pol III factors is controlled by cellular signals.
The DNA-binding activity of Pol III general transcription factors is regulated at multiple levels. Growth factors and nutrients can modulate the expression or post-translational modification of TFIIIC and TFIIIB, affecting their DNA-binding affinity. For instance, phosphorylation of TFIIIC subunits by mTOR or other kinases can alter its interaction with DNA. Tumor suppressors such as p53 can inhibit Pol III transcription by sequestering TFIIIB or by repressing the expression of Pol III factors, as shown for snRNA genes. Additionally, sequence-specific inhibition using Zorro LNA demonstrates that targeting the DNA elements themselves can block Pol III transcription. Chromatin remodeling complexes also regulate access to DNA, and cell type-specific chromatin looping can bring enhancers into contact with Pol III genes. These regulatory layers ensure that Pol III transcription is tightly coupled to cellular growth and stress signals.
Key Genes Involved in GO:0001016 RNA polymerase III transcription regulatory region sequence-specific DNA binding
The following genes encode proteins that directly or indirectly participate in RNA polymerase III transcription regulatory region sequence-specific DNA binding, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GTF3C1 | TFIIIC subunit, binds A-box and B-box elements | Essential for Pol III preinitiation complex assembly |
| GTF3C2 | TFIIIC subunit, DNA-binding component | Required for tRNA gene transcription |
| GTF3C5 | TFIIIC subunit, involved in TFIIIB recruitment | Target for studying Pol III regulation |
| GTF3C6 | TFIIIC subunit, stabilizes DNA binding | Potential role in chromatin looping |
| BDP1 | TFIIIB subunit, binds DNA and recruits Pol III | Key for transcription initiation |
| BRF1 | TFIIIB subunit, interacts with TBP and Pol III | Regulated by growth signals |
| TBP | TFIIIB subunit, recognizes TATA box | TATA box orientation affects Pol II/III specificity |
| POLR3A | Pol III largest subunit, contains DNA-binding domains | Mutations linked to disease |
| POLR3B | Pol III subunit, involved in termination | Sequence-specific termination signal recognition |
| POLR3C | Pol III subunit, contributes to DNA binding | Potential target for inhibition |
| POLR3D | Pol III subunit, part of core enzyme | Required for transcription |
| POLR3E | Pol III subunit, involved in initiation | Studied in elongation and termination |
| POLR3F | Pol III subunit, interacts with TFIIIB | Role in preinitiation complex |
| POLR3G | Pol III subunit, regulates enzyme activity | Linked to cell proliferation |
| POLR3H | Pol III subunit, contributes to DNA binding | Potential disease relevance |
| POLR3K | Pol III subunit, involved in termination | Sequence-specific signal recognition |
| TP53 | Represses Pol III transcription independently of sequence-specific DNA binding | Tumor suppressor, regulates snRNA genes |
How Is RNA polymerase III transcription regulatory region sequence-specific DNA binding Regulated?
The DNA-binding activity of Pol III transcription factors is regulated by cellular signaling pathways, including growth factor signaling and stress responses. For example, TFIIIC and TFIIIB are targets of phosphorylation by kinases such as mTOR, which can modulate their DNA-binding affinity and interaction with chromatin. Tumor suppressors like p53 can repress Pol III transcription by interfering with the recruitment of TFIIIB to DNA, as shown for snRNA genes. Additionally, sequence-specific inhibition of Pol III transcription can be achieved using antisense oligonucleotides like Zorro LNA, which target the DNA regulatory regions. Chromatin remodeling and histone modifications also influence access to Pol III regulatory regions, and cell type-specific chromatin looping can bring distal enhancers into contact with Pol III genes. These regulatory mechanisms ensure that Pol III transcription is responsive to cellular needs.
RNA polymerase III transcription regulatory region sequence-specific DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR3A | Hypomyelinating leukodystrophy | Knock-in mouse with patient mutation |
| POLR3B | Pol III-related leukodystrophy | Patient-derived iPSCs differentiated into oligodendrocytes |
| TP53 | Cancer (loss of repression of Pol III transcription) | TP53 knockout cancer cell lines |
| GTF3C1 | Cancer (upregulated Pol III activity) | Overexpression in cancer cell lines |
| BDP1 | Developmental disorders | Zebrafish knockout |
Cancer
Dysregulation of RNA polymerase III transcription is a hallmark of many cancers. Elevated Pol III activity supports the increased demand for tRNAs and ribosomal components in rapidly proliferating cells. Sequence-specific DNA binding by Pol III factors such as TFIIIC is often upregulated in cancer, and oncogenes like MYC can stimulate Pol III transcription by enhancing the recruitment of TFIIIB to DNA. Conversely, tumor suppressors like p53 repress Pol III transcription, and loss of p53 function leads to increased Pol III output. Targeting the DNA-binding activities of Pol III factors or the regulatory DNA elements themselves represents a potential therapeutic strategy.
Neurodegeneration
Mutations in Pol III subunits and its general transcription factors have been linked to neurodegenerative disorders, including hypomyelinating leukodystrophies and ataxia. For example, mutations in POLR3A and POLR3B cause Pol III-related leukodystrophy, characterized by defective myelination. These mutations can impair the DNA-binding and transcriptional activities of Pol III, leading to reduced synthesis of tRNAs and other small RNAs essential for neuronal function. Understanding how these mutations affect sequence-specific DNA binding at regulatory regions is crucial for developing targeted therapies.
Ribosomopathies and Developmental Disorders
Defects in Pol III transcription can lead to ribosomopathies, a group of diseases caused by impaired ribosome biogenesis. Since Pol III synthesizes 5S rRNA and tRNAs, mutations that disrupt its DNA-binding function can reduce protein synthesis and cause developmental abnormalities. For instance, mutations in TFIIIC subunits have been associated with growth retardation and craniofacial defects in model organisms. Studying the sequence-specific DNA binding of these factors provides insights into the molecular basis of these disorders.
From RNA polymerase III transcription regulatory region sequence-specific DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific point mutation in TFIIIC affect DNA binding? | Point mutation knock-in cell line |
| What is the effect of TFIIIC knockout on Pol III transcription? | CRISPR knockout in HEK293T cells |
| How does overexpression of BRF1 affect tRNA synthesis? | Doxycycline-inducible overexpression in HeLa cells |
| Can a tagged TFIIIC be used to map DNA binding sites? | Knock-in of FLAG-tagged GTF3C1 |
| Does a disease-associated mutation in POLR3A alter Pol III recruitment? | Patient iPSC-derived neurons |
| What genes regulate Pol III DNA binding? | Genome-wide CRISPR knockout library screen |
How to Study the RNA polymerase III transcription regulatory region sequence-specific DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding sites of Pol III factors | Mapping TFIIIC and TFIIIB binding |
| EMSA | In vitro sequence-specific DNA binding | Testing DNA probe mutations |
| Reporter assay | Transcriptional activity of Pol III regulatory regions | Validating DNA-binding sites |
| CRISPR screen | Genes regulating Pol III transcription | Identifying novel regulators |
| RNA-seq | Expression of Pol III-transcribed genes | Measuring tRNA and 5S rRNA levels |
| Proteomics | Protein composition of Pol III complexes | Identifying subunits and interactors |
| Zorro LNA inhibition | Sequence-specific inhibition of Pol III transcription | Targeting DNA regulatory regions |
| In vitro transcription | Pol III activity on defined templates | Studying elongation and termination |
Chromatin Immunoprecipitation (ChIP)
ChIP followed by sequencing (ChIP-seq) is used to map the genome-wide binding sites of Pol III transcription factors such as TFIIIC and TFIIIB. By crosslinking proteins to DNA and immunoprecipitating with specific antibodies, researchers can identify the regulatory regions bound by these factors. This method reveals sequence-specific binding patterns and can be combined with RNA-seq to correlate binding with transcription.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA is a classic technique to study sequence-specific DNA binding in vitro. A labeled DNA probe containing the regulatory region is incubated with protein extracts, and the formation of protein-DNA complexes is analyzed by gel electrophoresis. This method can determine binding affinity, specificity, and the effect of mutations in the DNA sequence.
Reporter Assays
Reporter assays use a luciferase or fluorescent reporter gene driven by a Pol III promoter containing the regulatory region of interest. By mutating the DNA-binding sites or overexpressing candidate transcription factors, researchers can measure the impact on Pol III transcription. This approach is useful for functional validation of DNA-binding events.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate Pol III transcription and DNA binding. For example, a screen using a Pol III-driven reporter can uncover novel factors that affect the sequence-specific DNA binding activity. These screens provide unbiased insights into the regulatory network.
How CRISPR Can Be Used to Study GO:0001016 RNA polymerase III transcription regulatory region sequence-specific DNA binding
Knockout
CRISPR knockout of genes encoding Pol III general transcription factors, such as GTF3C1 or BDP1, can abolish sequence-specific DNA binding and Pol III transcription. These models are used to study the essentiality of these factors and their downstream effects on cell growth and viability. Knockout cell lines also serve as negative controls in binding assays.
Point Mutation
Point mutations can be introduced into the DNA-binding domains of Pol III factors or into the regulatory DNA elements themselves. For example, mutating the A-box or B-box in a tRNA gene promoter can prevent TFIIIC binding, allowing researchers to dissect the contribution of individual base pairs to sequence-specific binding. Point mutation knock-in models are valuable for studying disease-associated variants.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous Pol III factor genes enables efficient ChIP-seq and proteomic analyses. Tagged knock-in cell lines allow for the mapping of DNA-binding sites with high specificity and the identification of interacting proteins. Additionally, knock-in of reporter genes under the control of Pol III regulatory regions facilitates live-cell imaging of transcription.
Overexpression
Overexpression of Pol III factors or their DNA-binding domains can lead to increased Pol III transcription and is often observed in cancer. CRISPR activation (CRISPRa) can be used to overexpress these genes, enabling studies of their oncogenic potential and the identification of downstream targets. Overexpression models are also useful for structural studies of DNA-binding complexes.
How EDITGENE Supports RNA polymerase III transcription regulatory region sequence-specific DNA binding Research
Researchers studying RNA polymerase III transcription regulatory region sequence-specific DNA binding-related genes often need to determine whether a candidate gene is causally involved in Pol III regulation, how mutations affect DNA binding, and what downstream transcriptional changes occur. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase III transcription regulatory region sequence-specific DNA binding research.
Frequently Asked Questions About RNA polymerase III transcription regulatory region sequence-specific DNA binding
What is GO:0001016?
GO:0001016 is a Gene Ontology molecular function term that describes binding to a DNA region controlling RNA polymerase III transcription, either sequence-specifically or after recruitment by other factors.
What genes are involved in RNA polymerase III transcription regulatory region sequence-specific DNA binding?
Key genes include GTF3C1, GTF3C2, BDP1, BRF1, TBP, and POLR3A, which encode subunits of TFIIIC, TFIIIB, and Pol III that recognize and bind regulatory DNA elements.
How does sequence-specific DNA binding regulate Pol III transcription?
Sequence-specific binding by factors like TFIIIC to A-box and B-box elements nucleates the assembly of the preinitiation complex, leading to transcription initiation.
What diseases are associated with defects in Pol III DNA binding?
Mutations in POLR3A and POLR3B cause hypomyelinating leukodystrophies, and dysregulated Pol III transcription is linked to cancer and ribosomopathies.
What methods are used to study Pol III regulatory region DNA binding?
Common methods include ChIP-seq, EMSA, reporter assays, and CRISPR screens, which map binding sites and measure transcriptional activity.
Can CRISPR be used to study Pol III transcription regulatory regions?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes and DNA elements involved in Pol III DNA binding.
What is the role of TFIIIC in Pol III transcription?
TFIIIC is a general transcription factor that binds A-box and B-box elements in tRNA genes, serving as a scaffold for TFIIIB and Pol III recruitment.
How is Pol III transcription terminated?
Termination involves a non-template strand sequence-specific signal element recognized by Pol III, leading to transcription termination.
Is Pol III transcription regulated by p53?
Yes, p53 represses Pol III transcription of snRNA genes independently of sequence-specific DNA binding, by interfering with factor recruitment.
What are the therapeutic implications of targeting Pol III DNA binding?
Inhibiting Pol III transcription by targeting its DNA-binding factors or regulatory elements could be a strategy for cancer therapy, as Pol III activity is often elevated in tumors.
Conclusion
GO:0001016, RNA polymerase III transcription regulatory region sequence-specific DNA binding, is a fundamental molecular function that governs the recruitment of Pol III to its target genes. Through the action of general transcription factors such as TFIIIC and TFIIIB, this activity ensures the precise synthesis of tRNAs, 5S rRNA, and other small RNAs essential for cellular function. Dysregulation of this process is implicated in cancer, neurodegeneration, and developmental disorders, making it a compelling area of research. Advances in CRISPR-based models and high-throughput methods now allow researchers to dissect the sequence-specific DNA binding events with unprecedented detail. EDITGENE's comprehensive services support these efforts, from knockout and point mutation models to library screening and bioinformatics, empowering discoveries in Pol III biology and beyond.
References
- 1. de Llobet Cucalon L et al.. 2022. An RNA Polymerase III General Transcription Factor Engages in Cell Type-Specific Chromatin Looping.. Int J Mol Sci 23(4) PMID: 35216376
- 2. Arimbasseri AG et al.. 2013. Transcription termination by the eukaryotic RNA polymerase III.. Biochim Biophys Acta 1829(3-4):318-30 PMID: 23099421
- 3. Ge R et al.. 2008. Sequence-specific inhibition of RNA polymerase III-dependent transcription using Zorro locked nucleic acid (LNA).. J Gene Med 10(1):101-9 PMID: 18023071
- 4. Arimbasseri AG et al.. 2015. Mechanism of Transcription Termination by RNA Polymerase III Utilizes a Non-template Strand Sequence-Specific Signal Element.. Mol Cell 58(6):1124-32 PMID: 25959395
- 5. Syroid DE et al.. 1994. RNA chain elongation and termination by mammalian RNA polymerase III. Analysis of tRNA gene transcription by imposing a reversible factor-mediated block to elongation using a sequence-specific DNA binding protein.. J Mol Biol 244(5):482-93 PMID: 7990136
- 6. Rambout X et al.. 2018. Beyond Transcription: Roles of Transcription Factors in Pre-mRNA Splicing.. Chem Rev 118(8):4339-4364 PMID: 29251915
- 7. Gridasova AA et al.. 2005. The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.. Mol Cell Biol 25(8):3247-60 PMID: 15798209
- 8. Wang Y et al.. 1995. RNA polymerase II/III transcription specificity determined by TATA box orientation.. Proc Natl Acad Sci U S A 92(19):8606-10 PMID: 7567983
